Clinical trial
Prognostic Value of CALLY Index, Frailty and SOFA-2 Score for Mortality in Geriatric Intensive Care Patients: A Prospective Cohort Study
NCT07579728 is registered in ClinicalTrials.gov with Istanbul University - Cerrahpasa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Value of CALLY Index, Frailty and SOFA-2 Score for Mortality in Geriatric Intensive Care Patients: A Prospective Cohort Study
- Lead sponsor
- Istanbul University - Cerrahpasa
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2026
- Completion date
- July 7, 2026
- Enrollment
- 138 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
critical illness, frailty, intensive care unit (icu)